A carregar...
Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir
Darunavir is currently the most recently approved HIV-1 protease inhibitor. It is approved for twice-daily dosing with ritonavir in treatment-experienced patients as young as 6 years of age and is available in numerous pill strengths. Emergence of darunavir-specific mutations is generally slow; ther...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2724190/ https://ncbi.nlm.nih.gov/pubmed/19707276 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|